Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registration.
Jon S HeiselmanBrett L EckerLiana Langdon-EmbryEileen M O'ReillyMichael I MigaWilliam R JarnaginRichard Kinh Gian DoNatally HorvatAlice C WeiJayasree ChakrabortyPublished in: Journal of medical imaging (Bellingham, Wash.) (2023)
Volumetric changes measured by longitudinal deformable image registration may yield imaging biomarkers to discriminate neoadjuvant treatment response in ill-defined tumors characteristic of PDAC. Registration-based biomarkers may help to overcome visual limits of radiographic evaluation to improve clinical outcome prediction and inform treatment selection.